Daily as of 3 Nov 16:00 ET
- Price
- above both $15.61 vs 50 $13.69 / 200 $12.25
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 🟨Golden cross 9 Jul 2026 · projected 29 bars out
BHVN | BiohavenNYSEHealthcareCommon stock golden cross and death cross projections, cross tests and history
$15.61
+$0.45 (+2.97%)
Biohaven (BHVN) is a NYSE-listed common stock that Cruxta has tracked for 50/200 crosses since 2023.
The 50 SMA has sat above the 200 on the daily since Jul 2026, with no cross projected inside the 30 bars Cruxta tracks. On both the daily and the 4-hour, price sits above the 50 and the 200; on the weekly it is between the two.
Timeframe summary
Weekly as of 30 Oct 16:00 ET
- Price
- between the two $15.42 vs 50 $11.98 / 200 $24.77
- Projection
- No cross projected
- Test
- No active test
- Last cross
- No cross on record
4-hour as of 3 Nov 13:30 ET
- Price
- above both $15.39 vs 50 $13.07 / 200 $14.06
- Projection
- 🟨Golden cross estimated in 14 to 19 bars
- Test
- No active test
- Last cross
- 💀Death cross 8 Oct 2026 · projected 23 bars out
Cross history
| Crossed | Direction | Timeframe | Projected | Cross test |
|---|---|---|---|---|
| 8 Oct 2026 | 💀Death | 4-hour | 23 bars out | Not tested |
| 9 Jul 2026 | 🟨Golden moderate | daily | 29 bars out | Not tested |
| 17 Jun 2026 | 🟨Golden | 4-hour | 24 bars out | Not tested |
| 12 Nov 2025 | 💀Death | 4-hour | 12 bars out | Not tested |
| 14 Oct 2025 | 🟨Golden | 4-hour | 18 bars out | — |
About BHVN
ExchangeNYSE
InstrumentCommon stock
Median $ volume, 60 d$31.5M
4-hour coverageYes, since Oct 2025
History on recordSince 2023
SectorHealthcare
Cap bandmid